Cytokines in rheumatoid arthritis: Localization in arthritic joint tissue and regulation in vitro

Scandinavian Journal of Rheumatology

Volumn 25, Issue SUPPL. 104, 1996, Pages 1-34

  Deleuran, Bent Winding ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

IL 4; IL 8; IL I; L 10; TNF receptors

Indexed keywords

ANTIRHEUMATIC AGENT; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONIC ACID; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 8; TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ARACHIDONIC ACID METABOLISM; CARTILAGE; CARTILAGE CELL; ENDOTHELIUM CELL; ENZYME ACTIVITY; FIBROBLAST; HUMAN; MONOCYTE; NEUTROPHIL; OSTEOBLAST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; ARTICLE; CHEMISTRY; CHEMOTAXIS; DRUG EFFECT; FORECASTING; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY;

ANTIRHEUMATIC AGENTS; ARACHIDONATE 15-LIPOXYGENASE; ARTHRITIS, RHEUMATOID; CHEMOTAXIS; CYTOKINES; FORECASTING; HUMANS; INTERLEUKINS; OSTEOBLASTS; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029885865     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009749609103783     Document Type: Article

References (257)

1. Haraoui B, Pelletier JP, Cloutier JM, Faure MP, Mar-tel Pelletier J. Synovial membrane histology and im-munopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of anti-rheumatic drugs. Arthritis Rheum 1991; 34:153-63.
2. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis ? Arthritis Rheum 1990; 33:768-73. (Pubitemid 20205755)
3. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986; 319:516-8. (Pubitemid 16212936)
4. Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986; 322:547-9. (Pubitemid 16049204)
5. Saklatvala J, Pilsworth LM, Sarsfield S J, Gavrilovic J, Heath JK. Pig catabolin is a form of interleukin l Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem J 1984; 224:461-6. (Pubitemid 15168438)
6. Scheurich P, Thoma B, Ucer U, Pflzenmaier K. Im-munoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol 1987; 138:1786-90. (Pubitemid 17040802)
7. Kehrl JH, Miller A, Fauci AS. Effect of tumor necrosis factor alpha on mitogen-activated human B cells. J Exp Med 1987; 166:786-91.
8. Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986; 77:645-8. (Pubitemid 16037670)
9. Fen-ante A, Nandoskar M, Bates EJ, Goh DH, Beard LJ. Tumour necrosis factor beta (lymphotoxin) inhibits locomotion and stimulates the respiratory burst and degranu-lation of neutrophils. Immunology 1988; 63:507-12.
10. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 1988; 167:1883-93.
11. Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989; 2:244-7. (Pubitemid 19180612)
12. Saxne T, Palladino MAJ, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988; 31:1041-5.
13. Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34:1125-32.
14. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991; 10:4025-31. (Pubitemid 21905432)
15. Elliott MJ, Maini RN, Feldmann M, Long Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 1993; 36:1681-90. (Pubitemid 23360007)
16. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α(cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344:1105-10. (Pubitemid 24317629)
17. Maini RN, Feldmann M, Long-Fox A, Charles P, Bijl H, Woody JN. Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis. Lancet 1994; 344:1125-6.
18. Weber JS, Rosenberg SA. Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro. Cancer Res 1988; 48:5818-24.
19. Warner SJ, Friedman GB, Libby P. Regulation of major histocompatibility gene expression in human vascular smooth muscle cells. Arteriosclerosis 1989; 9:279-88. (Pubitemid 19139862)
20. Gray PW, Barrett K, Chantry D, Turner M, Feldmann M. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Proc Natl Acad Sci U S A 1990; 87:7380-4.
21. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GH, et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990; 61:361-70. (Pubitemid 120035001)
22. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990; 248:1019-23.
23. Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, et al. Molecular cloning and expression of the human 55 kD tumor necrosis factor receptor. Cell 1990; 61:351-9.
24. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990; 87:3127-31.
25. Dembic Z, Loetscher H, Gubler U, Pan YC, Lahm HW, Gentz R, et al. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 1990; 2:231-7.
26. Espevik T, Brockhaus M, Loetscher H, Nonstad U, Shal-aby R. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J Exp Med 1990; 171:415-26. (Pubitemid 20059036)
27. Naume B, Shalaby R, Lesslauer W, Espevik T. Involvement of the 55-and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells. J Immunol 1991; 146:3045-8.
28. Heilig B, Mapara M, Brockhaus M, Krauth K, Dorken B. Two types of TNF receptors are expressed on human normal and malignant B lymphocytes. Clin Immunol Immunopathol 1991; 61:260-7.
29. Holtmann H, Wallach D. Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate. J Immunol 1987; 139:1161-7. (Pubitemid 17134180)
30. Ding AH, Sanchez E, Srimal S, Nathan CF. Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharide. J Biol Chem 1989; 264:3924-9. (Pubitemid 19072279)
31. Scheurich P, Kobrich G, Pfizenmaier K. Antagonistic control of tumor necrosis factor receptors by protein kinases A and C. Enhancement of TNF receptor synthesis by protein kinase A and transmodulation of receptors by protein kinase C. J Exp Med 1989; 170:947-58. (Pubitemid 19226675)
32. Aggarwal BB, Eessalu TE, Hass PE. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature 1985; 318:665-7. (Pubitemid 16172416)
33. Taylor DJ. Cytokine combinations increase p75 tumor necrosis factor receptor binding and stimulate receptor shedding in rheumatoid synovial fibroblasts. Arthritis Rheum 1994; 37:232-5. (Pubitemid 24065498)
34. Owen Schaub LB, Crump WL, Morin GI, Grimm EA. Regulation of lymphocyte tumor necrosis factor receptors by IL-2. J Immunol 1989; 143:2236-41. (Pubitemid 19245192)
35. Cope AP, Gibbons DL, Aderka D, Foxwell BM, Wallach D, Maini RN, et al. Differential regulation of tumour necrosis factor receptors (TNF-R) by IL4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells. Cytokine 1993; 5:205-12. (Pubitemid 23284474)
36. Ashkenazi A, Marsters SA, Capon DJ, Chamow SM, Figari IS, Pennica D, et al. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci USA 1991; 88:10535-39. (Pubitemid 21915870)
37. Heilig B, Wermann M, Gallati H, Brockhaus M, Berke B, Egen O, et al. Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Clin Investig 1992; 70:22-7.
38. Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC, et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1994;
39. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32:219-29. (Pubitemid 14184314)
40. Brennan FM, Gibbons DL, Mitchell T, Cope AP, Maini RN, Feldmann M. Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints. Eur J Immunol 1992; 22:1907-12.
41. Svendstrup L, Frydenberg J, Lind M, Thestrup-Pedersen K, Stengaard-Pedersen K, Deleuran B. B-cells synthesize, secrete and migrate towards IL-8. TNF alpha and gamma IP-10 are also B-cell migratory factors. (Submitted for publication).
42. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 1992; 89:9784-8.
43. Eisenberg SP, Brewer MT, Verderber E, Heimdal P, Brandhuber BJ, Thompson RC. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci USA 1991; 88:5232-6. (Pubitemid 21914718)
44. Lennard A, Gorman P, Carrier M, Griffiths S, Scotney H, Sheer D, et al. Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene. Cytokine 1992; 4:83-9.
45. Bomsztyk K, Sims JE, Stanton TH, Slack J, McMahan CJ, Valentine MA, et al. Evidence for different interleukin 1 receptors in murine B-and T-cell lines. Proc Natl Acad Sci USA 1989; 86:8034-8. (Pubitemid 19265314)
46. Arend WP. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 1991; 88:1445-51.
47. Chizzonite R, Truitt T, Kilian PL, Stern AS, Nunes P, Parker KP, et al. Two high-affinity interleukin 1 receptors represent separate gene products. Proc Natl Acad Sci USA 1989; 86:8029-33 (Pubitemid 19265313)
48. Auron PE, Webb AC, Rosenwasser LJ, Mucci SF, Rich A. Wolff SM, et al. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci USA 1984; 81:7907-11. (Pubitemid 15169171)
49. Lomedico PT, Gubler U, Hellmann CP, Dukovich M, Giri JG, Pan YC, et al. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 1984; 312:458-62.
50. Webb AC, Collins KL, Auron PE, Eddy RL, Nakai H, Byers MG, et al. Interleukin-1 gene (IL1) assigned to long arm of human chromosome 2. Lymphokine Res 1986; 5:77-85. (Pubitemid 16004493)
51. Fontana A, Hengartner H, Weber E, Fehr K, Grob PJ. Cohen G. Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 1982; 2:49-53. (Pubitemid 12023788)
52. Hopkins SJ, Humphreys M, Jayson MI. Cytokines in synovial fluid. I. The presence of biologically active and im-munoreactive IL-l Clin Exp Immunol 1988: 72:422-27.
53. Bendtzen K, Petersen J. Halkjaer Kristensen J, Ingemann Hansen T. Interleukin-1-like activities in synovial fluids of patients with rheumatoid arthritis and traumatic synovitis. Rheumatol Int 1985; 5:79-82. (Pubitemid 15167147)
54. Buchan G. Barrett K, Turner M. Chantry D, Maini RN. Feldmann M. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha. Clin Exp Immunol 1988; 73:449-55.
55. Chu CQ, Field M. Allard S. Abney E, Feldmann M, Maini RN. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 1992; 31:653-61.
56. Pettipher ER, Higgs GA, Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 1986; 83:8749-53. (Pubitemid 17194943)
57. Konig A, Muhlbauer RC. Fleisch H. Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]tetracycline excretion from prelabeled mice. J Bone Miner Res 1988; 3:621-7. (Pubitemid 19042548)
58. 2 responses by rat alveolar macrophages. Am J Pathol 1988; 130:489-95. (Pubitemid 18091377)
59. Pettipher ER, Henderson B. Moncada S, Higgs GA. Leucocyte infiltration and cartilage proteoglycan loss in immune arthritis in the rabbit. Br J Pharmacol 1988; 95:169-76.
60. Jinquan T, Deleuran B, Gesser B, Maare H, Deleuran M, Larsen CG, Thestrup-Pedersen K. Human T lymphocyte chemotaxis in vitro and its regulation by the T-cell derived cytokines. IL-2. IL-4, IL-10, IL-13 and IFN-γ. J Immunol 1995; 5:3742-52.
61. Henderson B. Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: Evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989; 75:306-10. (Pubitemid 19074265)
62. van de Loo FA. Arntz OJ, Otterness IG, van den Berg WB. Protection against cartilage proteoglycan synthesis inhibition by anti-interleukin 1 antibodies in experimental arthritis. J Rheumatol 1992; 19:348-56.
63. van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis 1993; 52:185-91. (Pubitemid 23094306)
64. Chin J, Rupp E, Cameron PM, MacNaul KL, Lotke PA, Tocci MJ, et al. Identification of a high-affinity receptor for interleukin 1 alpha and interleukin 1 beta on cultured human rheumatoid synovial cells. J Clin Invest 1988; 82:420-6.
65. Dower SK, Sims JE, Stanton TH, Slack J, McMa-han CJ, Valentine MA, et al. Molecular heterogeneity of interleukin-1 receptors. Ann NY Acad Sci 1990; 594:231-9. (Pubitemid 20298221)
66. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993; 261:472-5. (Pubitemid 23276556)
67. Mazzei GJ, Seckinger PL, Dayer JM, Shaw AR. Purification and characterization of a 26-kDa competitive inhibitor of interleukin l Eur J Immunol 1990; 20:683-9. (Pubitemid 20101312)
68. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990; 343:336-10.
69. Granowitz EV, Clark BD, Mancilla J, Dinarello CA. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem 1991; 266:14147-50. (Pubitemid 21907472)
70. Carter DB, Deibel MR,Jr., Dunn CJ, Tomich CS, Laborde AL, Slightom JL, et al. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990; 344:633-8.
71. Krane SM, Amento EP. Cellular interactions and control of collagenase secretion in the synovium. J Rheumatol Suppl 1983; 11:7-12. (Pubitemid 14173980)
72. Granowitz EV, Clark BD, Vannier E, Callahan MV, Dinarello CA. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Blood. 1992; 79:2356-63.
73. Mazzei GJ, Bernasconi LM, Lewis C, Mermod JJ, Kindler V, Shaw AR. Human granulocyte-macrophage colony-stimulating factor plus phorbol myristate acetate stimulate a promyelocytic cell line to produce an IL-1 inhibitor. J Immunol 1990; 145:585-91. (Pubitemid 20252366)
74. Shields J, Bernasconi LM, Benotto W, Shaw AR, Mazzei GJ. Production of a 26,000-dalton interleukin 1 inhibitor by human monocytes is regulated by granulocyte-macrophage colony-stimulating factor. Cytokine 1990; 2:122-8.
75. Turner M, Chantry D, Katsikis P, Berger A, Brennan FM, Feldmann M. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta. Eur J Immunol 1991; 21:1635-9.
76. van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-β age-related differences. Ann Rheum Dis 1994; 53:593-600. (Pubitemid 24302316)
77. Kindler V, Shields J, Ayer D, Benotto W, Mazzei GJ. Granulocyte- macrophage colony stimulating factor and interleukin-3 regulate the production of an interleukin-1 inhibitor by the differentiated AML-193 leukemic cell line. Eur Cytokine Netw 1990; 1:169-76.
78. Vannier E, Miller LC, Dinarello CA. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1992; 89:4076-80.
79. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992; 13:198-200.
80. Remvig L, Thomsen BS, Baek L, Svenson M, Bendtzen K. Interleukin 1, but not interleukin 1 inhibitor, is released from human monocytes by immune complexes. Scand J Immunol 1990; 32:255-61. (Pubitemid 20282380)
81. Kristensen M, Deleuran B, Eedy DJ, Feldmann M, Breath-nach SM, Brennan FM. Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis. Br J Dermatol 1992; 127:305-11.
82. Bertini R, Sironi M, Martin Padura I, Colotta F, Rambaldi S, Bernasconi S, et al. Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activation. Cytokine 1992; 4:44-7.
83. Haskill S, Martin G, Van Le L, Morris J, Peace A, Bigler CF, et al. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci USA 1991; 88:3681-5. (Pubitemid 21916687)
84. Arend WP, Joslin FG, Thompson RC, Hannum CH. An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties. J Immunol 1989; 143:1851-8. (Pubitemid 19241198)
85. DeForge LE, Tracey DE, Kenney JS, Remick DG. Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide- stimulated human whole blood. Am J Pathol 1992; 140:1045-54.
86. Arend WP, Coll BP. Interaction of recombinant monocyte-derived interleukin 1 receptor antagonist with rheumatoid synovial cells. Cytokine 1991; 3:407-13.
87. Henderson B, Thompson RC, Hardingham T, Lewthwaite J. Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. Cytokine 1991; 3:246-9.
88. Alexander HR, Doherty GM, Buresh CM, Venzon DJ, Norton JA. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J Exp Med 1991; 173:1029-32.
89. Firestein GS, Boyle GL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, et al. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994; 37:644-52. (Pubitemid 24145067)
90. Arend WP, Malyak M, Smith MF.Jr., Whisenand TD, Slack JL, Sims JE, et al. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol 1994; 153:4766-74. (Pubitemid 24346872)
91. Tanaka S, Robinson EA, Yoshimura T, Matsushima K, Leonard EJ, Appella E. Synthesis and biological characterization of monocyte-derived neutrophil chemotactic factor. FEBS Lett 1988; 236:467-70.
92. Walz A, Peveri P, Aschauer H, Baggiolini M. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Bio-phys Res Commun 1987; 149:755-61. (Pubitemid 18023044)
93. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K.The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243:1464-6. (Pubitemid 19087128)
94. Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988; 167:1547-59.
95. Schroder JM, Mrowietz U, Morita E, Christophers E. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 1987; 139:3474-83. (Pubitemid 18022004)
96. Modi WS, Dean M, Seuanez HN, Mukaida N, Matsushima K, O'Brien SJ. Monocyte-derived neutrophil chemotactic factor (MDNCF/TL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene super-family. Hum Genet 1990; 84:185-7. (Pubitemid 20043876)
97. Gimbrone MAJ, Obin MS, Brock AF, Luis EA, Hass PE, Hebert CA, et al. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 1989; 246:1601-3. (Pubitemid 20036693)
98. Schroder JM, Sticherling M, Henneicke HH, Preissner WC, Christophers E. IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-l/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol 1990; 144:2223-32. (Pubitemid 20106564)
99. Yoshimura T, Robinson EA, Appella E, Matsushima K, Showalter SD, Skeel A, et al. Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence. Mol Immunol 989; 26:87-93.
100. Kelner G S, Kennedy J, Bcaon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, et al. Lymphotactin: A cytokine that represents a new class of chemokine. Science 1995; 266:1395-9.
101. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ. Neutrophil chemotactic factor produced by lipopolysac-charide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). J Immunol 1987; 139:788-93. (Pubitemid 17107077)
102. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science 1991; 253:1278-80. (Pubitemid 21917277)
103. Grob PM, David E, Warren TC, DeLeon RP, Farina PR, Homon CA. Characterization of a receptoT for human monocyte-derived neutrophil chemotactic factor/interleukin-8. J Biol Chem 1990; 265:8311-6.
104. Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991; 253:1280-3. (Pubitemid 21917278)
105. Loetscher P, Seitz M, Clark Lewis I, Baggiolini M, Moser B. Both interleukin-8 receptors independently mediate chemotaxis. Jurkat cells transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GRO alpha and NAP-2. FEBS Lett 1994; 341:187-92. (Pubitemid 24102679)
106. Samanta AK, Oppenheim JJ, Matsushima K. Identification and characterization of specific receptors for monocyte-derived neutrophil chemotactic factor (MDNCF) on human neutrophils. J Exp Med 1989; 169:1185-9. (Pubitemid 19085849)
107. Djeu JY, Matsushima K, Oppenheim JJ, Shiotsuki K, Blanchard DK. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J Immunol 1990; 144:2205-10. (Pubitemid 20106561)
108. Thelen M, Peveri P, Kernen P, von Tscharner V, Walz A, Baggiolini M. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 1988; 2:2702-6.
109. Detmers PA, Lo SK, Olsen Egbert E. Walz A. Baggiolini M, Cohn ZA. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD 1 lb/CD 18 on human neutrophils. J Exp Med 1990: 171:1155-62. (Pubitemid 20120139)
110. Willems J, Joniau M, Cinque S, van Damme J. Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: comparison with other monokines. Immunology 1989; 67:540-2. (Pubitemid 19203696)
111. Strieter RM. Kasahara K. Allen RM. Standiford TJ. Rolfe MW, Becker FS. et al. Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 1992; 141:397-407.
112. Wertheim WA. Kunkel SL, Standiford TJ. Burdick MD, Becker FS, Wilke CA, et al. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2. dexamefha-sone, and IL-4. J Immunol 1993; 151:2166-75. (Pubitemid 23235690)
113. Endo H, Akahoshi T, Takagishi K. Kashiwazaki S. Mat-sushima K. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res. 1991: 10:245-252.
114. Elford PR. Cooper PH. Induction of neutrophil-mediated cartilage degradation by interleukin-8. Arthritis Rheum 1991: 34:325-332.
115. Endo H. Akahoshi T. Nishimura A. Tonegawa M. Takagishi K. Kashiwazaki S. et al. Experimental arthritis induced by continuous infusion of IL-8 into rabbit knee joints. Clin Exp Immunol 1994; 96:31-5. (Pubitemid 24213793)
116. Zachariae CO. Jinquan T. Nielsen V, Kaltoft K. Thestrup Pedersen K. Phenotypic determination of T-lymphocytes responding to chemotactic stimulation from fMLP. IL-8, human II.-10. and epidermal lymphocyte chemotactic factor. Arch Dermatol Res 1992: 284:333-8.
117. Oppenheim JJ. Zachariae CO. Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991: 9:617-48.
118. Moser B, Barella L, Mattei S. Schumacher C. Boulay F. Colombo MP, et al. Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem J 1993; 294:285-92. (Pubitemid 23251942)
119. Gesser B, Deleuran B. Lund M, Vestergaard C, Lohse N, Deleuran M. et al. Interleukin 8 (IL-8) induces its own production in T-cells. Inhibitory effects by IL-10. Biochem Biophys Res Commun 1995; 210:660-9
120. Larsen CG. Thomsen MK, Gesser B, Thomsen PD. Deleuran BW, Nowak J. et al. The delayed-type hypersensitivity reaction is dependent on IL-8. J Immunol 1995: 155:2151-7.
121. Kristensen MS, Paludan K. Larsen CG. Zachariae CO. Deleuran BW, Jensen PK. et al. Quantitative determination of IL-1 alpha-induced IL-8 mRNA levels in cultured human keratinocytes. dermal fibroblasts, endothelial cells, and monocytes. J Invest Dermatol 1991: 97:506-10.
122. Brown KA. Le Roy F. Noble G. Bacon K. Camp R, Vora A, et al. Interleukin 8 acts on monocytes to increase their attachment to cultured endothelium and enhance their expression of surface adhesion molecules. Adv Exp Cell Bio 1991: 305:161-2.
123. Koch AE. Kunkel SL. Burrows JC, Evanoff HL, Haines GK. Pope RM. et al. Synovial tissue macrophages as a source of the chemotactic cytokine IL-8. J Immunol 1991; 147:2187-95.
124. Kimata H, Yoshida A, Ishioka C, Lindley I. Mikawa H. Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells. J Exp Med 1992; 176:1227-31.
125. Carveth HJ, Bohnsack JF. Mclntyre TM, Baggiolini M, Prescott SM, Zimmerman GA. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. Biochem Biophys Res Commun 1989; 162:387-93. (Pubitemid 19185874)
126. Huber AR, Kunkel SL, Todd RF, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8 [published errata appear in Science 1991 Nov 1;254(5032):631 and 1991 Dec 6;254(5037):1435]. Science 1991; 254:99-102.
127. Smith WB, Gamble JR. Clark Lewis I, Vadas MA. Interleukin-8 induces neutrophil transendothelial migration. Immunology 1991; 72:65-72.
128. Rampart M, van Damme J, Zonnekeyn L, Herman AG. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am J Pathol 1989; 135:21-5. (Pubitemid 19228987)
129. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258:1798-801. (Pubitemid 23087348)
130. Lotz M, Kekow J, Carson DA. Transforming growth factor-beta and cellular immune responses in synovial fluids. J Immunol 1990; 144:4189-94. (Pubitemid 20187756)
131. Lotz M, Terkeltaub R, Villiger PM. Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. J Immunol 1992; 148:466-73.
132. Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology 1989; 68:31-6. (Pubitemid 19236065)
133. Unemori EN, Amento EP. Bauer EA, Horuk R. Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts. Regulation by C-X-C but not C-C cytokines. J Biol Chem 1993; 268:1338-12.
134. Chaudhary LR, Spelsberg TC, Riggs BL. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol. Endocrinolog 1992; 130:2528-34.
135. Birch MA, Ginty AF, Walsh CA, Fraser WD, Gallagher JA. Bilbe G. PCR detection of cytokines in normal human and pagetic osteoblast-like cells. J Bone Miner Res 1993; 8:1155-62. (Pubitemid 23308108)
136. Brennan FM, Zachariae CO, Chantry D, Larsen CG, Turner M, Maini RN, et al. Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 1990; 20:2141-1.
137. Akahoshi T, Endo H, Kondo H, Kashiwazaki S, Kasa-hara T, Mukaida N, et al. Essential involvement of interleukin-8 in neutrophil recruitment in rabbits with acute experimental arthritis induced by lipopolysaccha-ride and interleukin-l Lymphokine Cytokine Res 1994; 13:113-6. (Pubitemid 24136351)
138. Rathanaswami P, Hachicha M, Wong WL, Schall TJ, McColl SR. Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on interleukin-8 gene expression in synovial fibroblasts. Evidence that interleukin-8 is the major neutrophil-activating chemokine released in response to monokine activation. Arthritis Rheum 1993; 36:1295-304. (Pubitemid 23303120)
139. Miller EJ, Brelsford WG. Interleukin 8: the major neutrophil chemotaxin in a case of pseudogout. J Rheumatol 1993; 20:1250-2. (Pubitemid 23278190)
140. Darbonne WC, Rice GC, Mohler MA, Apple T, Hebert CA, Valente AJ, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991; 88:1362-9.
141. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993; 268:12247-9. (Pubitemid 23182370)
142. Peichl P, Ceska M, Effenberger F, Haberhauer G, Broell H, Lindley IJ. Presence of NAP-l/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand J Immunol 1991; 34:333-9.
143. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987; 84:9233-7.
144. Walz A, Baggiolini M. A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils. Biochem Biophys Res Commun 1989; 159:969-75. (Pubitemid 19101077)
145. Schroder JM, Persoon NL, Christophers E. Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/in-terleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity. J Exp Med 1990; 171:1091-100. (Pubitemid 20120135)
146. Luster AD, Ravetch JV. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 1987; 166:1084-97. (Pubitemid 18024248)
147. Richmond A, Balentien E, Thomas HG, Flaggs G, Barton DE, Spiess J, et al. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. EMBO J 1988; 7:2025-33.
148. Iida N, Grotendorst GR. Cloning and sequencing of a new gro transcript from activated human monocytes: expression in leukocytes and wound tissue [published erratum appears in Mol Cell Biol 1990 Dec;10(12):6821]. Mol Cell Biol 1990; 10:5596-9.
149. Deuel TF, Keim PS, Farmer M, Heinrikson RL. Amino acid sequence of human platelet factor 4. Proc Natl Acad Sci USA 1977; 74:2256-8. (Pubitemid 8110689)
150. Begg GS, Pepper DS, Chesterman CN, Morgan FJ. Complete covalent structure of human beta-thromboglobulin. Biochemistry 1978; 17:1739-14.
151. Farber JM. HuMig: a new human member of the chemokine family of cytokines. Biochem Biophys Res Commun 1993; 192:223-30. (Pubitemid 23205290)
152. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J Exp Med 1991; 174:1355-62.
153. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989; 169:1485-90. (Pubitemid 19104979)
154. van Damme J, Proost P, Lenaerts JP, Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med 1992; 176:59-65.
155. Schall TJ, Jongstra J, Dyer BJ, Jorgensen J, Clayberger C, Davis MM, et al. A human T cell-specific molecule is a member of a new gene family. J Immunol 1988: 141:1018-25.
156. Lipes MA, Napolitano M, Jeang KT, Chang NT, Leonard WJ. Identification, cloning, and characterization of an immune activation gene. Proc Natl Acad Sci USA 1988; 85:9704-8. (Pubitemid 19027193)
157. Orlofsky A, Berger MS, Prystowsky MB. Novel expression pattern of a new member of the MIP-1 family of cytokine-like genes. Cell Regul 1991; 2:403-12.
158. Miller MD, Hata S, de Waal Malefyt R, Krangel MS. A novel polypeptide secreted by activated human T lymphocytes. J Immunol 1989; 143:2907-16. (Pubitemid 19281837)
159. Terkeltaub R, Zachariae C, Santoro D, Martin J, Peveri P, Matsushima K. Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 1991; 34:894-903.
160. Tanabe M, Ochi T, Tomita T, Suzuki R, Sakata T, Shi-maoka Y, et al. Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis. J Rheumatol 1994; 21:830-5. (Pubitemid 24168664)
161. Strieter RM, Kasahara K, Allen R, Showell HJ, Standiford TJ, Kunkel SL. Human neutrophils exhibit disparate chemotactic factor gene expression. Biochem Biophys Res Commun 1990; 173:725-30.
162. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med 1991; 173:771-4.
163. Sica A, Matsushima K, van Damme J, Wang JM, Polen-tarutti N, Dejana E, et al. IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology 1990; 69:548-53. (Pubitemid 20123606)
164. Schroder JM, Christophers E. Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J Immunol 1989; 142:244-51. (Pubitemid 19034749)
165. Moller A, Lippert U, Lessmann D, Kolde G, Hamann K, Welker P, et al. Human mast cells produce IL-8. J Immunol 1993; 151:3261-6. (Pubitemid 23282638)
166. Tanimoto Y, Takahashi K, Kimura I. Effects of cytokines on human basophil chemotaxis. Clin Exp Allergy 1992; 22:1020-5.
167. Kuna P, Reddigari SR, Kornfeld D, Kaplan AP. IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3. J Immunol 1991; 147:1920-4.
168. Krieger M, Brunner T, Bischoff SC, von Tscharner V, Walz A, Moser B, et al. Activation of human basophils through the IL-8 receptor. J Immunol 1992; 149:2662-7.
169. Liao TN, Hsieh KH. Characterization of histamine-releasing activity: role of cytokines and IgE heterogeneity. J Clin Immunol 1992; 12:248-58.
170. Wang JM, Sica A, Peri G, Walter S, Padura IM, Libby P, et al. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb 1991; 11:1166-74.
171. Burrows LJ, Piper PJ, Lindley I, Baggiolini M, West-wick J. Human recombinant neutrophil-activating factor/interleukin-8 is a spasmogen of airway smooth muscle in vitro. Br J Pharmacol 1989; 98 Suppl:789P.
172. Klickstein LB. Shapleigh C, Goetzl EJ. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest 1980; 66:1166-70. (Pubitemid 11233819)
173. Fogh K, Larsen CG, Iversen L, Kragballe K. Interleukin-8 stimulates the formation of 15-hydroxy-eicosatetraenoic acid by human neutrophils in vitro. Agents Actions 1992; 35:227-31.
174. Schroder JM. The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate. J Exp Med 1989; 170:847-63.
175. Fogh K, Herlin T, Kragballe K. In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils. Arch Dermatol Res 1988; 280:430-6.
176. Ternowitz T, Fogh K, Kragballe K. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils. Skin Pharmacol 1988; 1:93-9. (Pubitemid 19182382)
177. 4-induced skin response. Arch Dermatol Res 1989; 281:401-5. (Pubitemid 19262478)
178. Fogh K, Hansen ES, Herlin T, Knudsen V, Henrik-sen TB, Ewald H, et al. 15-Hydroxy-eicosatetraenoic acid (15-HETE) inhibits carrageenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4). Prostaglandins 1989; 37:213-28. (Pubitemid 19090451)
179. Vanderhoek JY, Bryant RW, Bailey JM. Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. J Biol Chem 1980; 255:10064-6.
180. Miossec P, Dinarello CA, Ziff M. Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum 1986; 29:461-70. (Pubitemid 16118694)
181. Rathanaswami P, Hachicha M, Sadick M, Schall TJ, Mc-Coll SR. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 1993; 268:5834-9. (Pubitemid 23090915)
182. Bedard PA, Golds EE. Cytokine-induced expression of mRNAs for chemotactic factors in human synovial cells and fibroblasts. J Cell Physiol 1993; 154:433-41. (Pubitemid 23048025)
183. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994; 179:1517-27. (Pubitemid 24129569)
184. Dowd PM, Kobza Black A, Woollard PM, Camp RD, Greaves MW. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE). J Invest Dermatol 1985; 84:537-41. (Pubitemid 15053213)
185. Feldmann M. Brennan FM, Chantry D, Haworth C, Turner M, Katsikis P, et al. Cytokine assays: role in evaluation of the pathogenesis of autoimmunity. Immunol Rev 1991; 119:105-23.
186. Miltenburg AM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC. T cells cloned from human rheumatoid synovial membrane functionally represent the Thl subset. Scand J Immunol 1992; 35:603-10.
187. Quayle AJ, Chomarat P, Miossec P, Kjeldsen Kragh J, Forre O, Natvig JB. Rheumatoid inflammatory T-cell clones express mostly Thl but also Th2 and mixed (ThO-like) cytokine patterns. Scand J Immunol 1993; 38:75-82. (Pubitemid 23196410)
188. Standiford TJ, Strieter RM, Chensue SW, Westwick J, Kasahara K, Kunkel SL. IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol 1990; 145:1435-9. (Pubitemid 20255050)
189. 2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma. J Immunol 1989; 143:3020-4. (Pubitemid 19281854)
190. Jansen JH, Wientjens GJ, Fibbe WE, Willemze R, Kluin Nelemans H C. Inhibition of human macrophage colony formation by interleukin 4. J Exp Med 1989; 170:577-82. (Pubitemid 19204283)
191. Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez Valdez H, Banchereau J. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum 992; 35:874-83.
192. Briolay J, Dechanet J, Blanchard D, Banchereau J, Miossec P. Interleukin 4 inhibits polyclonal immunoglobulin secretion and cytokine production by peripheral blood mononuclear cells from rheumatoid arthritis patients. J Clin Immunol 1992; 12:36-44.
193. Dechanet J, Briolay J, Rissoan MC, Chomarat P, Gal-izzi JP, Banchereau J, et al. IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J Immunol 1993; 151:4908-17. (Pubitemid 23318544)
194. Feghali CA, Bost KL, Boulware DW, Levy LS. Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblasts. Clin Immunol Immunopathol 1992; 63:182-7.
195. Postlethwaite AE, Seyer JM. Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. J Clin Invest 1991; 87:2147-52.
196. Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1992; 90:1479-85.
197. Ueno K, Katayama T, Miyamoto T, Koshihara Y. Interleukin-4 enhances in vitro mineralization in human osteoblast-like cells. Biochem Biophys Res Commun 1992; 189:1521-6. (Pubitemid 23041333)
198. Conrad DJ, Kuhn H, Mulkins M, Highland E, Sigal E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci USA 1992; 89:217-21.
199. Allen JB, Wong HL, Costa GL, Bienkowski MJ, Wahl SM. Suppression of monocyte function and differential regulation of IL-1 and IL-lra by IL-4 contribute to resolution of experimental arthritis. J Immunol 1993; 151:4344-51. (Pubitemid 23298768)
200. Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 1994; 24:2699-705. (Pubitemid 24342185)
201. te Velde AA, Klomp JP, Yard BA, de Vries JE, Figdor CG. Modulation of phenotypic and functional properties of human peripheral blood monocytes by JL-4. J Immunol 1988; 140:1548-54.
202. Paleolog EM, Aluri GR, Feldmann M. Contrasting effects of interferon gamma and interleukin 4 on responses of human vascular endothelial cells to tumour necrosis factor alpha. Cytokine 1992; 4:470-8.
203. Piela Smith TH, Broketa G, Hand A, Korn JH. Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4. J Immunol 1992; 148:1375-81.
204. Morales Ducret J, Wayner E, Elices MJ, Alvaro Gracia JM, Zvaifler NJ, Firestein GS. Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol 1992; 149:1424-31.
205. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
206. Benjamin D, Knobloch TJ, Dayton MA. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 1992; 80:1289-98.
207. Vieira P, de Waal Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 1991; 88:1172-6. (Pubitemid 21916187)
208. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze Koops H, Davis LS, et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:96-104.
209. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174:915-24.
210. Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992; 148:1143-8.
211. Taga K, Mostowski H, Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood 1993; 81:2964-71 (Pubitemid 23162114)
212. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Thl cells. J Immunol 1991; 146:3444-51.
213. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147:3815-22.
214. Jinquan T, Larsen CG, Gesser B, Matsushima K, Thestrup Pedersen K. Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J Immunol 1993; 151:4545-51. (Pubitemid 23318508)
215. Van Vlasselaer P, Borremans B, Van Den Heuvel R, Van Gorp U, de Waal Malefyt R. Interleukin-10 inhibits the osteogenic activity of mouse bone marrow. Blood 1993: 82:2361-70. (Pubitemid 23304259)
216. Taga K, Chretien J, Cherney B, Diaz L, Brown M, Tosato G. Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells. J Clin Invest 1994; 94:251-60. (Pubitemid 24218099)
217. Taga K, Cherney B, Tosato G. IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. Int Immunol 1993; 5:1599-608. (Pubitemid 24008920)
218. Fluckiger AC, Durand I, Banchereau J. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 1994; 179:91-9. (Pubitemid 24012974)
219. Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, et al. Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 1995; 154:1432-9.
220. Brennan FM, Chantry D, Jackson AM, Maini RN, Feldmann M. Cytokine production in culture by cells isolated from the synovial membrane. J Autoimmun 1989; 2 Suppl: 177-86.
221. Goddard DH, Grossman SL, Newton R, Clark MA, Bo-malaski JS. Regulation of synovial cell growth: basic fibroblast growth factor synergizes with interleukin 1 beta stimulating phospholipase A2 enzyme activity, phospho-lipase A2 activating protein production and release of prostaglandin E2 by rheumatoid arthritis synovial cells in culture. Cytokine 1992; 4:377-84.
222. Gautam S, Tebo JM, Hamilton TA. IL-4 suppresses cytokine gene expression induced by IFN-gamma and/or IL-2 in murine peritoneal macrophages. J Immunol 1992; 148:1725-30.
223. Schorlemmer HU, Kanzy EJ, Langner KD, Kurrie R. Immunomodulatory activity of recombinant IL-1 receptor (IL-l-R) on models of experimental rheumatoid arthritis. Agents Actions 1993; 39 Spec No:C113-6.
224. Deleuran M. Regulation of the chemotactic cytokines IL-8 and MCAF and their induction in different cell types related to the skin. Acta Derm Venereol Suppl Stockh 1994; 189:1-17.
225. Zachariae COC. Chemotactic cytokines and inflammation. Biological properties of the lymphocyte and monocyte chemotatic factors ELCF, MCAF and IL-8. Acta Derm Venereol Suppl Stockh 1994; 181:1-37. (Pubitemid 23267560)
226. Madhok R, Crilly A, Murphy E, Smith J, Watson J, Capell HA. Gold therapy lowers serum interleukin 6 levels in rheumatoid arthritis. J Rheumatol 1993; 20:630-33. (Pubitemid 23138849)
227. Barrera P, Boerbooms AM, Janssen EM, Sauerwein RW, Gallati H, Mulder J, et al. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum 1993; 36:1070-9. (Pubitemid 23229283)
228. Hu SK, Mitcho YL, Oronsky AL, Kerwar SS. Studies on the effect of methotrexate on macrophage function. J Rheumatol 1988; 15:206-9. (Pubitemid 18073739)
229. Johnson WJ, DiMartino MJ, Meunier PC, Muirhead KA, Hanna N. Methotrexate inhibits macrophage activation as well as vascular and cellular inflammatory events in rat adjuvant induced arthritis. J Rheumatol 1988; 15:745-9.
230. Seitz M, Dewald B, Ceska M, Gerber N, Baggiolini M. Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol Int 1992; 12:159-64.
231. Griswold DE, Lee JC, Poste G, Hanna N. Modulation of macrophage- lymphocyte interactions by the antiarthritic gold compound, auranofin. J Rheumatol 1985; 12:490-7. (Pubitemid 15004946)
232. Haynes DR, Garrett IR, Whitehouse MW, Vernon Roberts B. Do gold drugs inhibit interleukin-1? Evidence from an vitro lymphocyte activating factor assay. J Rheumatol 1988; 15:775-8.
233. Loetscher P, Dewald B. Baggiolini M, Seitz M. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of antirheumatic drugs. Cytokine 1994; 6:162-70. (Pubitemid 24263855)
234. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990: 33:305-15. (Pubitemid 20109181)
235. Iguchi T, Ziff M. Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest 1986; 77:355-61. (Pubitemid 16037632)
236. Cavender D, Saegusa Y, Ziff M. Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J Immunol 1987; 139:1855-60. (Pubitemid 17141614)
237. Ziff M. Lymphocyte migration in the rheumatoid synovial membrane. Int J Tissue React 1987; 9:267-71. (Pubitemid 17112038)
238. 3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochem Biophys Res Com-mun 1991: 176:1020-6.
239. Kristensen M. Deleuran B, Jinquan T. Thomsen MK. Zachariae C, Paludan K. et al. ETH-615. a synthetic inhibitor of leukotriene biosynthesis and function, also inhibits the production and activity of interleukin 8. Exp Dermatol 1993; 2:165-70. (Pubitemid 24009472)
240. Remvig L. Enk C, Bligaard N. Effect of auranotin and sodium aurothiomalate on interleukin-1 production from human monocytes in vitro. Scand J Rheumatol 1988: 17:255-62.
241. Minty A, Chalon P, Derocq JM. Dumont X, Guillemot JC, Kaghad M. et al. Interleukin-13 is a new human lym-phokine regulating inflammatory and immune responses. Nature 1993; 362:248-50. (Pubitemid 23093630)
242. McKenzie AN. Li X. Largaespada DA, Sato A, Kaneda A, Zurawski SM, et al. Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J Immunol 1993; 150:5436-44. (Pubitemid 23180657)
243. Punnonen J, Aversa G. Cocks BG, McKenzie AN, Menon S, Zurawski G, et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993; 90:3730-4. (Pubitemid 23111441)
244. Cocks BG, de Waal Malefyt R, Galizzi JP, de Vries JE, Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 1993; 5:657-63. (Pubitemid 23209420)
245. de Waal Malefyt R, Figdor C, Huijbens RJ, Mohan-Peterson S, Bennett B, Culpepper J, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J Immunol 1994;
246. Sironi M, Sciacca FL, Matteucci C, Conni M, Vec-chi A, Bernasconi S, et al. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 1994; 84:1913-21.
247. Colotta F, Re F, Muzio M, Polentarutti N, Minty A, Caput D, et al. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J Biol Chem 1994; 269:12403-6. (Pubitemid 24202015)
248. Doherty TM, Kastelein R, Menon S, Andrade S, Coffman RL. Modulation of murine macrophage function by IL-13. J Immunol 1993; 151:7151-60. (Pubitemid 24001089)
249. Zurawski SM, Vega FJ, Huyghe B, Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 1993; 12:2663-70. (Pubitemid 23218315)
250. Aversa G, Punnonen J, Cocks BG, de Waal Malefyt R, Vega F,Jr., Zurawski SM, et al. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 1993; 178:2213-8. (Pubitemid 23344880)
251. merz Bertling C, Duschl A. Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J Biol Chem 1995; 270:966-70.
252. Geiger T, Arnold J, Rordorf C, Henn R, Vosbeck K. Interferon-gamma overcomes the glucocorticoid-mediated and the interleukin-4-mediated inhibition of interleukin-1 beta synthesis in human monocytes. Lym-phokine Cytokine Res 1993; 12:271-8. (Pubitemid 23305109)
253. Als OS, Christiansen C, Hellesen C. Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment. Clin Rheumatol 1984; 3:201-8.
254. ambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S. Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 1987; 30:721-8. (Pubitemid 17145208)
255. Shioi A, Teitelbaum SL, Ross FP, Welgus HG, Suzuki H, Ohara J, et al. Interleukin 4 inhibits murine osteoclast formation in vitro. J Cell Biochem 1991; 47:272-7.
256. Lind M, Deleuran B, Thestrup Pedersen K, Søballe K, Eriksen EF, Bunger C. Chemotaxis of human osteoblasts. Effects of osteotropic growth factors. APMIS 1995; 103:140-6.
257. Lind M, Schumacker B, Søballe K, Keller J, Melsen F, Bunger C. Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Acta Orthop Scand 1993; 64:553-6. (Pubitemid 23329864)